Evidence map›Paper›PMID 41608346›Full record

ReviewWorld journal of clinical oncology2026

Single-cell differential abundance detection: A new angle on dissecting tumor heterogeneity.

Ying-Xue Xiao, Jing Sun, Ling-Ling Xie, Yue Zou, Tong Li, You-Jin Hao, Bo Li

Abstract readReview
In one paragraph

Review in World journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying-Xue XiaoCollege of Life Sciences, Chongqing Normal University, Chongqing 401331, China.
Jing SunCollege of Life Sciences, Chongqing Normal University, Chongqing 401331, China.
Ling-Ling XieCollege of Life Sciences, Chongqing Normal University, Chongqing 401331, China.
Yue ZouCollege of Life Sciences, Chongqing Normal University, Chongqing 401331, China.
Tong LiCollege of Life Sciences, Chongqing Normal University, Chongqing 401331, China.
You-Jin HaoCollege of Life Sciences, Chongqing Normal University, Chongqing 401331, China.
Bo LiCollege of Life Sciences, Chongqing Normal University, Chongqing 401331, China. libcell@cqnu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor heterogeneity is one of the central challenges in oncology, contributing to treatment resistance and disease recurrence. Bulk RNA sequencing has advanced understanding of tumor biology, yet its averaging effect conceals cell type-specific alterations. Single-cell RNA sequencing overcomes this limitation by capturing gene expression and cellular phenotypes with high-resolution, thereby illuminating tumor composition and the surrounding microenvironment. Within this framework, differential abundance (DA) detection has emerged as a powerful strategy to quantify shifts in cell population proportions across conditions. Unlike differential gene expression, DA highlights compositional changes in cellular ecosystems, offering a structural perspective on tumor dynamics. This review introduces the main categories of DA methods in single-cell RNA sequencing analysis, outlining their modeling strategies, assumptions, and representative applications in oncology. We also discuss key challenges, including reliance on clustering quality and batch correction. By linking methodological principles with biological insight, this review clarifies the role of DA detection in single-cell oncology and provides a conceptual framework for integrating compositional analysis into efforts to understand tumor evolution, treatment response, and disease stratification.

Indexed as

Cellular compositionDifferential abundance detectionImmune remodelingPrecision oncologySingle-cell RNA sequencingTumor heterogeneityTumor microenvironment

Identifiers

PMID41608346
PMCPMC12836066

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.